HomepageBEIGF • OTCMKTS
add
Beigene Ltd
Vorige slotkoers
$ 15,95
Jaar-range
$ 13,68 - $ 20,61
Beurswaarde
32,11 mld. USD
Koers/winst
-
Dividendrendement
-
In het nieuws
Financiële informatie
Resultatenrekening
Opbrengst
Netto inkomsten
| (USD) | mrt 2025info | Wijziging j-o-j |
|---|---|---|
Opbrengst | 1,12 mld. | 48,64% |
Bedrijfskosten | 941,18 mln. | 5,98% |
Netto inkomsten | 1,27 mln. | 100,51% |
Netto winstmarge | 0,11 | 100,33% |
Winst per aandeel | 0,01 | 100,41% |
EBITDA | 42,73 mln. | 118,01% |
Effectief belastingtarief | 93,92% | — |
Balans
Totale activa
Totale passiva
| (USD) | mrt 2025info | Wijziging j-o-j |
|---|---|---|
Contanten en kortetermijnbeleggingen | 2,52 mld. | -9,91% |
Totale activa | 5,84 mld. | 3,07% |
Totale passiva | 2,34 mld. | 1,50% |
Totaal aandelenvermogen | 3,50 mld. | — |
Uitstaande aandelen | 107,95 mln. | — |
Koers-boekwaardeverhouding | 0,49 | — |
Rendement op activa | 0,47% | — |
Rendement op kapitaal | 0,62% | — |
Kasstroom
Nettomutatie in liquide middelen
| (USD) | mrt 2025info | Wijziging j-o-j |
|---|---|---|
Netto inkomsten | 1,27 mln. | 100,51% |
Operationele kasstroom | 44,08 mln. | 114,29% |
Kasstroom uit beleggingen | -121,94 mln. | 41,89% |
Kasstroom uit financiering | -33,78 mln. | -120,81% |
Nettomutatie in liquide middelen | -108,16 mln. | 71,43% |
Vrije kasstroom | -145,31 mln. | 62,90% |
Over
BeOne Medicines, formerly known as BeiGene, Ltd. is a multinational oncology company. It specializes in the development of drugs for cancer treatment.
Founded in 2010 by chief executive officer John V. Oyler and Xiaodong Wang, the company is headquartered in Cambridge, Massachusetts and has locations on six continents, in over 45 countries. BeOne has a large presence in the Chinese market.
BeOne Medicines has developed several medicines, including tislelizumab, a checkpoint inhibitor, and zanubrutinib, a Bruton's tyrosine kinase inhibitor. On 14 November 2024 the company announced its intention to rebrand as BeOne Medicines. BeOne changed its stock ticker to ONC in January 2025 and redomiciled to Basel, Switzerland in May 2025. Wikipedia
Opgericht
28 okt 2010
Website
Werknemers
11.000
